when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

pharmadog news

Browse

1,093 stories matching this filter · ← front page

★ save view ↓export CSV

rangeto

sort

recent oldest source alpha

source

STAT810 Endpoints608 BioPharma Dive231 onclive165 Fierce Biotech78 BioSpace78 raps32 fda press20

therapy area

all Oncology81 Cardiology27 Psychiatry & CNS21 Vaccines17 Immunology17 Rare Disease12 Hepatology

A trend that isn’t fading, ultra-processed baby foods
An FDA advisory panel serves some peptide wins, a measles record, and more health news from Morning Rounds
STAT · 2d agoRegulatoryNeutral↗ source
Opinion: How midwives like me can help fight medical misinformation
“I have come to believe that changing a mind is rarely the point. Planting a seed is,” writes nurse-midwife Mara Evans.
STAT · 2d agoRegulatoryNeutral↗ source

page 3 of 44

globenewswire health20

6

Infectious Disease4

STAT+: As some medical schools embrace RFK Jr.’s nutrition push, they deftly sidestep MAHA priorities

Even as some medical schools heed health secretary Robert F. Kennedy Jr.’s call for more nutrition education, several told STAT that they plan to steer clear of topics that aren’t…

STAT · 2d agoRegulatoryNeutral↗ source

Opinion: E-bikes, e-scooters are a burgeoning pediatric public health emergency

“Emergency departments across America report dramatic increases in serious injuries from e-bikes and e-scooters,” write CHOP’s J. Todd R. Lawrence and Madison A. Kesler.

STAT · 2d agoRegulatoryNeutral↗ source

‘This could be a large market’: Novo Holdings-backed Claris secures $118M for corneal disease drug

A new biotech has come into view with a $118 million series B and a vision for making the front of the eye front-of-mind.

Fierce Biotech · 1d agoNeutral↗ source

Apnimed aspires for up to $160M IPO as sleep apnea pill launch nears

Apnimed has detailed its plans for an initial public offering, with the biotech intending to raise as much as $160 million to fund the launch of its sleep apnea pill.

Fierce Biotech · 2d agoNeutral↗ source

MapLight shares sink on mixed phase 2 schizophrenia readout

MapLight Therapeutics’ stock plummeted more than 60% this morning after the neuro outfit dropped mixed results for a phase 2 trial of its experimental schizophrenia treatment.

Fierce Biotech · 2d agoNeutral↗ source

Legend Biotech CEO abruptly steps down without permanent replacement

In a sudden leadership shift, Legend Biotech announced that its CEO, Ying Huang, Ph.D., resigned on Friday, with no permanent replacement yet named.

Fierce Biotech · 2d agoNeutral↗ source

FDA panel backs compounding of epitalon, rejects emideltide in narrow vote

The FDA advisory committee voted to allow compounding pharmacies to produce the peptide epitalon, while narrowly voting against allowing the production of emideltide. The decision follows the pane…

STAT · 4d agoRegulatoryNeutral↗ source

U.S. measles cases in 2026 already exceed total from record-breaking 2025 year

The CDC reports 2,318 measles cases in the United States so far in 2026, surpassing the 2,289 cases recorded for the entire year of 2025. The increase makes 2026 the worst measles year since 1991,…

STAT · 4d agoNeutral↗ source

Rigel Pharmaceuticals appoints Alison Hannah as executive vice president and chief medical officer

Rigel Pharmaceuticals announced that it has hired Alison Hannah to serve as executive vice president and chief medical officer. Hannah joins Rigel after holding the same senior medical leadership…

STAT · 4d agoPositive↗ source

Former FDA food safety chief warns nutrition push may overlook cyclospora outbreak risks

Susan Mayne, who led the FDA’s Center for Food Safety and Applied Nutrition from 2015 to 2023, argues that nutrition and food safety cannot be treated separately. She says the two are linked and bo…

STAT · 4d agoNeutral↗ source

Amgen sheds around 40 staffers amid continuing struggles

Amgen has laid off around 40 employees as part of “organizational changes” meant to better align operations with the company’s strategic objectives, Fierce has learned.

Fierce Biotech · 4d ago↗ source

STAT+: Fatal gene-editing trial in China raises ethics and oversight questions

Sanofi insulin pen in short supply, a win for peptide compounds, and more biotech news from The Readout

STAT · 5d ago↗ source

STAT+: Pharmalittle: We’re reading about an FDA panel and peptides, a Merck license for an HIV pill, and more

In a win for peptide proponents, an FDA advisory panel recommended compounding pharmacies be allowed to make four of the drugs

STAT · 5d ago↗ source

Study of Yescarta patients reveals genetic red flags for CAR-T therapy side effects

A new analysis of patients who took part in clinical trials for Kite Pharma’s CAR-T cell therapy Yescarta has revealed genetic signatures of toxicity risk, potentially providing a path forward for…

Fierce Biotech · 5d ago↗ source

A new, separate outbreak of the diarrhea-causing parasite

A win for peptide proponents, autism advisory committees clash, and more health news from Morning Rounds

STAT · 5d ago↗ source

STAT+: Merck strikes voluntary licensing deals in poor countries for an experimental HIV prevention pill

Merck is striking licensing deals for its experimental HIV prevention pill in hope of getting wide-scale production started quickly.

STAT · 5d ago↗ source

Merck stages expanded access to monthly HIV PrEP pill ahead of approval

Following in the footsteps of Gilead, Merck has signed voluntary licensing agreements to enable access to its investigational HIV PrEP pill alimatravir ahead of any regulatory submissions.

Fierce Biotech · 5d ago↗ source

Opinion: I may be one of the last middle-class medical students who could afford to become a doctor

A federal loan program made it possible for Gauri Gurumurthy to pursue medicine. Now that program is changing.

STAT · 5d ago↗ source

Opinion: The U.S. pharmaceutical supply chain problem is not about China

The national security framing of the discussion around pharmaceutical supply chain vulnerabilities is a distraction, writes Pooja Yerramilli.

STAT · 5d ago↗ source

Senate advances MAHA-friendly bill for food warning labels and junk food ad bans

Unexpected alliances among Republicans and Democrats were on display over a bill meant to rein in ultra-processed foods.

STAT · 5d ago↗ source

STAT+: White House offers its science blueprint: More AI, less life sciences

The Trump administration released its blueprint for U.S. science, calling for shifting hundreds of billions of research dollars from universities to industry.

STAT · 5d ago↗ source

Sanofi abandons plan to seek approval for eczema drug from $1.1B Kymab buyout

Sanofi has abandoned plans to seek approval for amlitelimab in atopic dermatitis, admitting that a drug once tipped as a potential blockbuster “would not represent a meaningful improvement” to exis…

Fierce Biotech · 5d ago↗ source

Sunny Pharmtech, Inc. Issues Voluntary Nationwide Recall of Cyclophosphamide for Injection, USP to the User Level Due to the Presence of Particulate Matter

July 24, 2026 - Taoyuan City, Taiwan - Sunny Pharmtech, Inc is voluntarily recalling three lots of Cyclophosphamide for Injection, USP, 1g/vial and 2g/vial, to the User Level due to the presence of…

fda recalls · 5d ago↗ source